Document is current

Any future updates will be listed below

Development of a hybrid paclitaxel-loaded arsenite nanoparticle (HPAN) delivery system for synergistic combined therapy of paclitaxel-resistant cancer

Crossref DOI link: https://doi.org/10.1007/s11051-017-3848-0

Published Online: 2017-04-20

Published Print: 2017-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark